Cas:69048-70-0 Dimethyl 4-nitroisophthalate manufacturer & supplier

We serve Chemical Name:Dimethyl 4-nitroisophthalate CAS:69048-70-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Dimethyl 4-nitroisophthalate

Chemical Name:Dimethyl 4-nitroisophthalate
CAS.NO:69048-70-0
Synonyms:4-nitro-isoindoline-1,3-dione,potassium-compound;potassium 3-nitrophthalimide;3-Nitrophthalimid-kalium;Kalium-Verbindung von 4-Nitro-isoindolin-1,3-dion;4-Nitro-isophthalsaeure-dimethylester;Dimethyl4-Nitroisophthalate;4-Nitro-isoindolin-1,3-dion,Kalium-Verbindung;4-nitro-isophthalic acid dimethyl ester;3-nitrophthalimide potassium;(3-NITROPHTHALIMIDO)POTASSIUM
Molecular Formula:C10H9NO6
Molecular Weight:239.18200
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:98.42000
Exact Mass:239.04300
LogP:1.69120

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4-nitro-isoindoline-1,3-dione,potassium-compound chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(3-NITROPHTHALIMIDO)POTASSIUM physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-nitro-isophthalic acid dimethyl ester Use and application,Kalium-Verbindung von 4-Nitro-isoindolin-1,3-dion technical grade,usp/ep/jp grade.


Related News: As part of the deal, CROS NT CEO Paolo Morelli becomes Alira’s executive vice president of biometrics. Dimethyl 4-nitroisophthalate manufacturer Once they have decided how to make the compound, our staff in the production department manufacture a high quantity of APIs using the large reactors in our plant. Dimethyl 4-nitroisophthalate supplier What’s the background? Dimethyl 4-nitroisophthalate vendor The GLOW trial doesn’t yet have the answer to that question, but Tendler pointed to encouraging early evidence from the regimen’s phase 2 trial, dubbed CAPTIVATE. Among eight patients who progressed after stopping the fixed-duration combo, six responded to subsequent Imbruvica monotherapy, while the other two didn’t have a response report, according to data presented at the recent American Society of Clinical Oncology annual meeting. Dimethyl 4-nitroisophthalate factory These mathematical dosing algorithms were developed in the Damiano Lab at Boston University and refined based on results from home-use clinical trials in adults and children with T1D. Beta Bionics is a Certified B Corporation? whose founders �� in addition to Ed Damiano �� include other parents of children with type 1 diabetes and people with type 1 diabetes. Beta Bionics is committed to acting in the best interests of the diabetes community and to profoundly disrupting the diabetes medical device industry by bringing the iLet to market as expeditiously and responsibly as possible.